ATLAS / Macro Radar / Reporting / INBX

Inhibrx Biosciences, Inc. (INBX) reporting calendar

Inhibrx Biosciences, Inc. files periodic reports with the SEC as INBX on Nasdaq. Atlas tracks 8 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
28 Jul 2026 – 31 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
8

How this window is derived. Derived from this issuer's own filing history: 8 periods at a median 92-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open INBX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0002007919-26-000027
10-K31 Dec 202519 Mar 202678 days0002007919-26-000006
10-Q30 Sep 202514 Nov 202545 days0002007919-25-000093
10-Q30 Jun 202513 Aug 202544 days0002007919-25-000081
10-Q31 Mar 202514 May 202544 days0002007919-25-000056
10-K31 Dec 202417 Mar 202576 days0002007919-25-000019
10-Q30 Sep 202414 Nov 202445 days0002007919-24-000058
10-Q30 Jun 202413 Aug 202444 days0002007919-24-000029

Source: SEC EDGAR company submissions for CIK 0002007919. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.